PGD2 and CRTH2 counteract Type 2 cytokine-elicited intestinal epithelial responses during helminth infection.
Oyebola O OyesolaMichael T ShanahanMatt KankeBridget M MooneyLauren M WebbShuchi SmitaMacy K MathesonPamela CampioliDuc H PhamSimon P FrühJohn W McGintyMadeline J ChurchillJordan L CahoonPavithra SundaravaradanBecca A FlitterKarthik MouliMarija S NadjsombatiElena KamyninaSeth A PengRebecca L CubittKarsten GronertJames D LordIsabella RauchJakob von MoltkePraveen SethupathyElia D Tait WojnoPublished in: The Journal of experimental medicine (2021)
Type 2 inflammation is associated with epithelial cell responses, including goblet cell hyperplasia, that promote worm expulsion during intestinal helminth infection. How these epithelial responses are regulated remains incompletely understood. Here, we show that mice deficient in the prostaglandin D2 (PGD2) receptor CRTH2 and mice with CRTH2 deficiency only in nonhematopoietic cells exhibited enhanced worm clearance and intestinal goblet cell hyperplasia following infection with the helminth Nippostrongylus brasiliensis. Small intestinal stem, goblet, and tuft cells expressed CRTH2. CRTH2-deficient small intestinal organoids showed enhanced budding and terminal differentiation to the goblet cell lineage. During helminth infection or in organoids, PGD2 and CRTH2 down-regulated intestinal epithelial Il13ra1 expression and reversed Type 2 cytokine-mediated suppression of epithelial cell proliferation and promotion of goblet cell accumulation. These data show that the PGD2-CRTH2 pathway negatively regulates the Type 2 cytokine-driven epithelial program, revealing a mechanism that can temper the highly inflammatory effects of the anti-helminth response.
Keyphrases
- single cell
- cell therapy
- cell proliferation
- induced apoptosis
- oxidative stress
- rheumatoid arthritis
- poor prognosis
- cell cycle arrest
- type diabetes
- cell death
- mesenchymal stem cells
- signaling pathway
- insulin resistance
- skeletal muscle
- metabolic syndrome
- high fat diet induced
- cell cycle
- systemic sclerosis
- stem cells
- disease activity
- long non coding rna
- wild type
- pi k akt
- binding protein
- interstitial lung disease
- deep learning
- replacement therapy
- cell fate